Subscribe to RSS
![](/products/assets/desktop/img/oa-logo.png)
DOI: 10.1055/s-0041-1729145
Clinical Features and Maternal-fetal Results of Pregnant Women in COVID-19 Times
Características clínicas e resultados materno-fetais de mulheres grávidas com COVID-19![](https://www.thieme-connect.de/media/10.1055-s-00030576/202105/lookinside/thumbnails/10-1055-s-0041-1729145_200151-1.jpg)
Abstract
Objective Coronavirus disease 2019 (COVID-19) is a disease caused by a newly discovered coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which usually leads to non-specific respiratory symptoms. Although pregnant women are considered at risk for respiratory infections by other viruses, such as SARS and Middle East respiratory syndrome (MERS), little is known about their vulnerability to SARS-CoV-2. Therefore, this study aims to identify and present the main studies on the topic, including the postpartum period.
Methods In this narrative review, articles were searched in various databases, organizations, and health entities using keywords compatible with medical subject headings (MeSH), such as: COVID-19, pregnancy, vertical transmission, coronavirus 2019, and SARS-CoV-2.
Results The review of the scientific literature on the subject revealed that pregnant women with COVID-19 did not present clinical manifestations significantly different from those of non-pregnant women; however, there are contraindicated therapies. Regarding fetuses, studies were identified that reported that infection by SARS-CoV-2 in pregnant women can cause fetal distress, breathing difficulties and premature birth, but there is no substantial evidence of vertical transmission.
Conclusion Due to the lack of adequate information and the limitations of the analyzed studies, it is necessary to provide detailed clinical data on pregnant women infected with SARS-CoV-2 and on the maternal-fetal repercussions caused by this infection. Thus, this review may contribute to expand the knowledge of professionals working in the area as well as to guide more advanced studies on the risk related to pregnant women and their newborns. Meanwhile, monitoring of confirmed or suspected pregnant women with COVID-19 is essential, including in the postpartum period.
Resumo
Objetivo A Coronavirus disease 2019 (COVID-19) é uma doença causada por um coronavírus recém descoberto, o severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), que geralmente leva a sintomas respiratórios não específicos. Embora mulheres grávidas sejam consideradas em risco de infecções respiratórias por outros vírus, como SARS e Middle East respiratory syndrome (MERS), pouco se sabe sobre sua vulnerabilidade ao SARS-CoV-2. Portanto, este estudo tem como objetivo identificar e apresentar os principais estudos sobre o tema incluindo o período pós-parto.
Métodos Nesta revisão narrativa, foram pesquisados artigos em diversas bases de dados, organizações e entidades de saúde, utilizando palavras-chave compatíveis com o MeSH, tais como: COVID-19, gravidez, transmissão vertical, coronavírus 2019, e SARS-CoV-2.
Resultados A revisão da literatura científica sobre o assunto revelou que as gestantes com COVID-19 não apresentaram manifestações clínicas significativamente diferentes das não gestantes, porém existem terapias contraindicadas. Em relação aos fetos, foram identificados estudos que relataram que a infecção por SARS-CoV-2 em mulheres grávidas pode causar sofrimento fetal, dificuldades respiratórias e parto prematuro, mas não há evidências substanciais de transmissão vertical.
Conclusão Devido à falta de informações adequadas e às limitações dos estudos analisados, é necessário fornecer dados clínicos detalhados sobre as gestantes infectadas pelo SARS-CoV-2 e sobre as repercussões materno-fetais causadas por esta infecção. Assim, esta revisão pode contribuir para ampliar o conhecimento dos profissionais que atuam na área, bem como para orientar estudos mais avançados sobre o risco relacionado à gestante e seu recém-nascido. Enquanto isso, o monitoramento de gestantes confirmadas ou suspeitas com COVID-19 é essencial, incluindo o pós-parto.
Publication History
Received: 06 May 2020
Accepted: 04 February 2021
Article published online:
28 June 2021
© 2021. Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. Am J Obstet Gynecol 2020; 222 (05) 415-426 DOI: 10.1016/j.ajog.2020.02.017.
- 2 Wong SF, Chow KM, Leung TN. et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol 2004; 191 (01) 292-297 DOI: 10.1016/j.ajog.2003.11.019.
- 3 Schwartz DA, Graham AL. Potential maternal and infant outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: lessons from SARS, MERS, and other human coronavirus infections. Viruses 2020; 12 (02) 194 DOI: 10.3390/v12020194.
- 4 Zhu N, Zhang D, Wang W. et al; China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med 2020; 382 (08) 727-733 DOI: 10.1056/NEJMoa2001017.
- 5 Wuhan City Health Committee. Wuhan Municipal Health and Health Commission's briefing on the current pneumonia epidemic situation in our city 2019 [Internet]. 2019 [cited 2020 Apr 9]. Available from: http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989
- 6 World Health Organization. Coronavirus disease (COVID-19): Q&A [Internet]. 2020 [cited 2020 Mar 25]. Available from: https://www.who.int/news-room/q-a-detail/q-a-coronaviruses
- 7 Guan WJ, Ni ZY, Hu Y. et al; China Medical Treatment Expert Group for Covid-19. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720 DOI: 10.1056/NEJMoa2002032.
- 8 Yu N, Li W, Kang Q. et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre, descriptive study. Lancet Infect Dis 2020; 20 (05) 559-564 DOI: 10.1016/S1473-3099(20)30176-6.
- 9 WHO Coronavirus Disease (COVID-19) Dashboard [Internet]. 2020 [cited 2020 May 12]. Available from: https://covid19.who.int/
- 10 Ministério da Saúde. Painel Coronavírus [Internet]. 2020 [cited 2020 May 26]. Available from: https://covid.saude.gov.br/
- 11 Ministério da Saúde. Secretaria de Vigilância em Saúde. Doença pelo Coronavírus COVID-19. Brasília (DF): Ministério da Saúde; 2020. . p. 43. (Boletim Epidemiológico Especial; no. 25)
- 12 Wong JEL, Leo YS, Tan CC. COVID-19 in Singapore-current experience: critical global issues that require attention and action. JAMA 2020; 323 (13) 1243-1244 DOI: 10.1001/jama.2020.2467.
- 13 American College of Obstetricians and Gynecologists. Novel Coronavirus 2019 (COVID-19) [Internet]. 2020 [cited 2020 Apr 11]. Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/03/novel-coronavirus-2019
- 14 Qiao J. What are the risks of COVID-19 infection in pregnant women?. Lancet 2020; 395 (10226): 760-762 DOI: 10.1016/S0140-6736(20)30365-2.
- 15 Ministério da Saúde. Secretaria de Atenção Primária à Saúde (SAPS). Protocolo de manejo clínico do CoronaVírus (COVID-19) na atenção primária à saúde: versão 7. Brasília (DF): Ministério da Saúde; 2020
- 16 Ministério da Saúde. Secretaria de Atenção Especializada à Saúde. Departamento de Atenção Hospitalar, Domiciliar e de Urgência. Protocolo de manejo clínico da Covid-19 na atenção especializada. Brasíla (DF): Ministério da Saúde; 2020
- 17 Favre G, Pomar L, Musso D, Baud D. 2019-nCoV epidemic: what about pregnancies?. Lancet 2020; 395 (10224): e40 DOI: 10.1016/S0140-6736(20)30311-1.
- 18 Favre G, Pomar L, Qi X, Nielsen-Saines K, Musso D, Baud D. Guidelines for pregnant women with suspected SARS-CoV-2 infection. Lancet Infect Dis 2020; 20 (06) 652-653 DOI: 10.1016/S1473-3099(20)30157-2.
- 19 Li N, Han L, Peng M. et al. Maternal and neonatal outcomes of pregnant women with COVID-19 pneumonia: a case-control study. Clin Infect Dis 2020; 71 (16) 2035-2041 DOI: 10.1093/cid/ciaa352.
- 20 Ellington S, Strid P, Tong VT. et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (25) 769-775 DOI: 10.15585/mmwr.mm6925a1.
- 21 Wu X, Sun R, Chen J, Xie Y, Zhang S, Wang X. Radiological findings and clinical characteristics of pregnant women with COVID-19 pneumonia. Int J Gynaecol Obstet 2020; 150 (01) 58-63 DOI: 10.1002/ijgo.13165.
- 22 Jing Y, Run-Qian L, Hao-Ran W. et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod 2020; 26 (06) 367-373 DOI: 10.1093/molehr/gaaa030.
- 23 Pringle KG, Tadros MA, Callister RJ, Lumbers ER. The expression and localization of the human placental prorenin/renin-angiotensin system throughout pregnancy: roles in trophoblast invasion and angiogenesis?. Placenta 2011; 32 (12) 956-962 DOI: 10.1016/j.placenta.2011.09.020.
- 24 Zhou P, Yang XL, Wang XG. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579 (7798): 270-273 DOI: 10.1038/s41586-020-2012-7.
- 25 Mariani Neto C. Nótula complementar sobre COVID-19 e aleitamento materno [Internet]. 2020 [cited 2020 May 26]. Available from: www.febrasgo.org.br/pt/noticias/item/949-notula-complementar-sobre-covid-19-e-aleitamento-materno
- 26 Mendoza M, Garcia-Ruiz I, Maiz N. et al. Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study. BJOG 2020; 127 (11) 1374-1380 DOI: 10.1111/1471-0528.16339.
- 27 Zhang L, Jiang Y, Wei M. et al. [Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei Province]. Zhonghua Fu Chan Ke Za Zhi 2020; 55 (03) 166-171 DOI: 10.3760/cma.j.cn112141-20200218-00111. Chinese
- 28 Chen H, Guo J, Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet 2020; 395 (10226): 809-815 DOI: 10.1016/S0140-6736(20)30360-3.
- 29 Chen R, Zhang Y, Huang L, Cheng BH, Xia ZY, Meng QT. Safety and efficacy of different anesthetic regimens for parturients with COVID-19 undergoing Cesarean delivery: a case series of 17 patients. Can J Anaesth 2020; 67 (06) 655-663 DOI: 10.1007/s12630-020-01630-7.
- 30 Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect 2020;•••:S0163-4453(20)30109-2. Doi: 10.1016/j.jinf.2020.02.028 [ahead of print.]
- 31 Zambrano LI, Fuentes-Barahona IC, Bejarano-Torres DA. et al. A pregnant woman with COVID-19 in Central America. Travel Med Infect Dis 2020; 36: 101639 DOI: 10.1016/j.tmaid.2020.101639.
- 32 Yang P, Wang X, Liu P. et al. Clinical characteristics and risk assessment of newborns born to mothers with COVID-19. J Clin Virol 2020; 127: 104356 DOI: 10.1016/j.jcv.2020.104356.
- 33 Xiong X, Wei H, Zhang Z. et al. Vaginal delivery report of a healthy neonate born to a convalescent mother with COVID–19. J Med Virol 2020; 92 (09) 1657-1659 DOI: 10.1002/jmv.25857.
- 34 Wang S, Guo L, Chen L. et al. A case report of neonatal 2019 Coronavirus Disease in China. Clin Infect Dis 2020; 71 (15) 853-857 DOI: 10.1093/cid/ciaa225.
- 35 Khan S, Peng L, Siddique R. et al. Impact of COVID-19 infection on pregnancy outcomes and the risk of maternal-to-neonatal intrapartum transmission of COVID-19 during natural birth. Infect Control Hosp Epidemiol 2020; 41 (06) 748-750 DOI: 10.1017/ice.2020.84.
- 36 Chen Y, Peng H, Wang L. et al. Infants born to mothers with a New Coronavirus (COVID-19). Front Pediatr 2020; 8: 104 DOI: 10.3389/fped.2020.00104.
- 37 Liu D, Li L, Wu X. et al. Pregnancy and perinatal outcomes of women with Coronavirus Disease (COVID-19) pneumonia: a preliminary analysis. AJR Am J Roentgenol 2020; 215 (01) 127-132 DOI: 10.2214/AJR.20.23072.
- 38 Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis 2020; 71 (15) 844-846 DOI: 10.1093/cid/ciaa200.
- 39 Zhu H, Wang L, Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9 (01) 51-60 DOI: 10.21037/tp.2020.02.06.
- 40 Iqbal SN, Overcash R, Mokhtari N. et al. An uncomplicated delivery in a patient with Covid-19 in the United States. N Engl J Med 2020; 382 (16) e34 DOI: 10.1056/NEJMc2007605.
- 41 Chen S, Liao E, Cao D, Gao Y, Sun G, Shao Y. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia. J Med Virol 2020; 92 (09) 1556-1561 DOI: 10.1002/jmv.25789.
- 42 Dong L, Tian J, He S. et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA 2020; 323 (18) 1846-1848 DOI: 10.1001/jama.2020.4621.
- 43 Fan C, Lei D, Fang C. et al. Perinatal transmission of COVID-19 associated SARS-CoV-2: should we worry?. Clin Infect Dis 2020; •••: ciaa226 DOI: 10.1093/cid/ciaa226. [ahead of print]
- 44 Poon LC, Yang H, Lee JCS. et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol 2020; 55 (05) 700-708 DOI: 10.1002/uog.22013.
- 45 Cheyne H. Pregnant during the coronavirus crisis? Don't panic [Internet]. 2020 [cited 2020 May 26]. Available from: https://theconversation.com/pregnant-during-the-coronavirus-crisis-dont-panic-135108
- 46 Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Departamento de Ações Programáticas Estratégicas. Coordenação-Geral de Ciclos da Vida. Coordenação de Saúde das Mulheres. Nota Técnica no. 7/2020-COSMU/CGCIVI/DAPES/SAPS/MS: trata das orientações a serem adotadas na atenção à saúde das gestantes no contexto da pandemia do novo coronavírus (SARS-CoV-2) [Internet]. 2020 [cited 2020 Apr 16]. Available from: https://portaldeboaspraticas.iff.fiocruz.br/biblioteca/gestantes-nota-tecnica-no-6-2020-cosmu-cgcivi-dapes-saps-ms/
- 47 Secretaria de Estado de Saúde de Minas Gerais. Centro de Operações de Emergência em Saúde. Nota Técnica COES Minas COVID-19 no. 19/2020, de 1 de abril de 2020. Orientações ao atendimento de gestantes e puérperas no cenário de enfrentamento da doença do Coronavírus (COVID-19) [Internet]. 2020 [cited 2020 Apr 26]. Available from: https://www.saude.mg.gov.br/images/noticias_e_eventos/000_2020/Coronav%C3%ADrus/Nota_T%C3%A9cnica_COES_n%C2%BA_19.pdf
- 48 Boulware DR, Pullen MF, Bangdiwala AS. et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 2020; 383 (06) 517-525 DOI: 10.1056/NEJMoa2016638.
- 49 Rosenberg ES, Dufort EM, Udo T. et al. Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State. JAMA 2020; 323 (24) 2493-2502 DOI: 10.1001/jama.2020.8630.
- 50 Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Departamento de Gestão e Incorporação de Tecnologias e Inovação em Saúde. Coordenação-Geral de Gestão de Tecnologias em Saúde. Coordenação de Gestão de Protocolos Clínicos e Diretrizes Terapêuticas. Diretrizes para diagnóstico e tratamento da COVID-19. Brasília (DF): Ministério da Saúde; 2020
- 51 McCoy JA, Short WR, Srinivas SK, Levine LD, Hirshberg A. Compassionate use of remdesivir for treatment of severe coronavirus disease 2019 in pregnant women at a United States academic center. Am J Obstet Gynecol MFM 2020; 2 (03) 100164 DOI: 10.1016/j.ajogmf.2020.100164.
- 52 Lim S, DeBruin DA, Leider JP. et al. Developing an ethics framework for allocating remdesivir in the COVID-19 pandemic. Mayo Clin Proc 2020; 95 (09) 1946-1954 DOI: 10.1016/j.mayocp.2020.06.016.
- 53 Tookey PA, Thorne C, van Wyk J, Norton M. Maternal and foetal outcomes among 4118 women with HIV infection treated with lopinavir/ritonavir during pregnancy: analysis of population-based surveillance data from the national study of HIV in pregnancy and childhood in the United Kingdom and Ireland. BMC Infect Dis 2016; 16: 65 DOI: 10.1186/s12879-016-1400-y.
- 54 Hellwig K, Duarte Caron F, Wicklein EM, Bhatti A, Adamo A. Pregnancy outcomes from the global pharmacovigilance database on interferon beta-1b exposure. Ther Adv Neurol Disorder 2020; 13: 1756286420910310 DOI: 10.1177/1756286420910310.
- 55 Lacroix I, Bénévent J, Damase-Michel C. Chloroquine and hydroxychloroquine during pregnancy: What do we know?. Therapie 2020; 75 (04) 384-385 DOI: 10.1016/j.therap.2020.05.004.
- 56 Sperber K, Hom C, Chao CP, Shapiro D, Ash J. Systematic review of hydroxychloroquine use in pregnant patients with autoimmune diseases. Pediatr Rheumatol Online J 2009; 7: 9 DOI: 10.1186/1546-0096-7-9.
- 57 Keskin-Arslan E, Kaplan YC, Koren G. Use of azithromycin during pregnancy and breastfeeding: a coronavirus pandemic (COVID-19) update. Motherisk Int J. 2020; 1: 12
- 58 World Health Organization. “Solidarity” clinical trial for COVID-19 treatments [Internet] 2020 [cited 2020 Apr 12]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments
- 59 Ministério da Saúde. Orientações do Ministério da Saúde para manuseio medicamentoso precoce de pacientes com diagnóstico da COVID-19. Brasília (DF): Ministério da Saúde; 2020
- 60 Centers for Disease Control and Prevention. Interim considerations for infection prevention and control of Coronavirus Disease 2019 (COVID-19) in inpatient obstetric healthcare settings [Internet]. 2020 [cited 2020 Apr 02]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-for-ems.html
- 61 Davanzo R, Mosca F, Moro G, Sandri F, Agosti M. Allattamento e infezione da SARS-CoV-2 (Coronavirus Disease 2019 - COVID-19) [Internet]. 2020 [cited 2020 Apr 26]. Available from: https://www.policlinico.mi.it/uploads/fom/attachments/pagine/pagine_m/79/files/allegati/539/allattamento_e_infezione_da_sars-cov-2_indicazioni_ad_interim_della_societ___italiana_di_neonatologia_sin__2_.pdf
- 62 Centers for Disease Control and Prevention. Evaluation and management considerations for neonates at risk for COVID-19 [Internet]. 2020 [cited 2020 Jul 25]. Available from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html
- 63 World Health Organization. Breastfeeding and COVID-19 [Internet]. 2020 [cited 2020 Jul 25]. Available from: www.who.int/news-room/commentaries/detail/breastfeeding-and-covid-19
- 64 World Health Organization. Clinical management of severe acute respiratory infection when COVID-19 is suspected [Internet]. 2020 [cited 2020 Jul 25]. Available from: https://apps.who.int/iris/bitstream/handle/10665/331446/WHO-2019-nCoV-clinical-2020.4-eng.pdf?sequence=1&isAllowed=y
- 65 World Health Organization. WHO statement on caesarean section rates [Internet]. 2015 [cited 2020 May 10]. Available from: https://www.who.int/reproductivehealth/publications/maternal_perinatal_health/cs-statement/en/
- 66 Matar R, Alrahmani L, Monzer N. et al. Clinical presentation and outcomes of pregnant women with COVID-19: a systematic review and meta-analysis. Clin Infect Dis 2020; •••: ciaa828 DOI: 10.1093/cid/ciaa828. [ahead of print]
- 67 Li M, Chen L, Zhang J, Xiong C, Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 2020; 15 (04) e0230295 DOI: 10.1371/journal.pone.0230295.
- 68 Li Y, Zhao R, Zheng S. et al. Lack of vertical transmission of severe acute respiratory syndrome Coronavirus 2, China. Emerg Infect Dis 2020; 26 (06) 1335-1336 DOI: 10.3201/eid2606.200287.
- 69 Zeng H, Xu C, Fan J. et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA 2020; 323 (18) 1848-1849 DOI: 10.1001/jama.2020.4861.